How to Effectively Treat Chronic Gastritis with Pyloric Gland Hyperplasia

Chronic gastritis accompanied by pyloric gland hyperplasia is a relatively common condition. If a biopsy reveals glandular hyperplasia or intestinal metaplasia, and it is diagnosed as mild type I epithelial hyperplasia, regular follow-up for 1-2 years may be sufficient. In some cases, patients may also consider taking certain patent Chinese medicines or herbal remedies to help improve the condition of the gastric mucosa.

For moderate or severe cases, more frequent gastroscopic monitoring is generally recommended. This allows doctors to closely observe any changes in the gastric lining and respond promptly if necessary. When high-grade or severe atypical hyperplasia is detected, immediate intervention becomes crucial.

Endoscopic treatment options include endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD), both of which can effectively treat early-stage tumors. These minimally invasive techniques allow for precise removal of abnormal tissue while preserving the surrounding healthy areas.

In some instances, after endoscopic removal of the lesion, if a detailed pathological examination of the excised tissue reveals early cancerous changes with deeper invasion, an additional surgical procedure may be advised to ensure complete eradication of the disease.

Early detection and timely management are key in achieving the best outcomes for patients with chronic gastritis and associated hyperplasia. Regular check-ups and following medical advice can significantly reduce the risk of progression to more serious conditions.